Cargando…
Lower serum triglyceride level is a risk factor for in-hospital and late major adverse events in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention- a cohort study
BACKGROUND: Whether serum triglyceride level correlates with clinical outcomes of patients with ST segment elevation myocardial infarction (STEMI) treated by primary percutaneous coronary intervention (pPCI) remains unclear. METHODS: From June 2008 to February 2012, all patients with STEMI who were...
Autores principales: | Cheng, Yu-Tsung, Liu, Tsun-Jui, Lai, Hui-Chin, Lee, Wen-Lieng, Ho, Hung-Yun, Su, Chieh-Shou, Liu, Chia-Ning, Wang, Kuo-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197277/ https://www.ncbi.nlm.nih.gov/pubmed/25303974 http://dx.doi.org/10.1186/1471-2261-14-143 |
Ejemplares similares
-
Association of triglyceride levels with adverse cardiovascular events in patients with ST-segment elevation myocardial infarction
por: Yildiz, Mehmet, et al.
Publicado: (2023) -
Triglyceride-Glucose Index and New-Onset Atrial Fibrillation in ST-Segment Elevation Myocardial Infarction Patients After Percutaneous Coronary Intervention
por: Ling, Yang, et al.
Publicado: (2022) -
Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
por: Gao, Lei, et al.
Publicado: (2014) -
Impact of high triglyceride/high-density lipoprotein cholesterol ratio (insulin resistance) in ST-segment elevation myocardial infarction
por: Chen, Huang-Chung, et al.
Publicado: (2020) -
No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Gupta, Sanjiv, et al.
Publicado: (2016)